Literature DB >> 17465871

Marine-Lenhart syndrome and radioiodine-131 treatment.

Dimitrios Chatzopoulos1, Ioannis Iakovou, Efstratios Moralidis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17465871     DOI： 10.1089/thy.2006.0150

Source DB:  PubMed          Journal:  Thyroid        ISSN： 1050-7256            Impact factor:   6.568


× No keyword cloud information.
  4 in total

1.  Prevalence and Treatment Outcomes of Marine-Lenhart Syndrome in Japan.

Authors:  Hirosuke Danno; Eijun Nishihara; Kazuyoshi Kousaka; Tomohiko Nakamura; Toshihiko Kasahara; Takumi Kudo; Mitsuru Ito; Shuji Fukata; Mitsushige Nishikawa; Akira Miyauchi
Journal:  Eur Thyroid J       Date:  2020-09-30

2.  Marine-Lenhart syndrome with papillary thyroid carcinoma.

Authors:  Hulusi Atmaca; Ramis Çolak; Zihni Acar Yazici; Mehmet Kefeli; Fevziye Canbaz Tosun
Journal:  J Res Med Sci       Date:  2015-04       Impact factor: 1.852

3.  Marine-Lenhart Syndrome: Case Report, Diagnosis, and Management.

Authors:  Danielle Neuman; Russ Kuker; Francesco Vendrame
Journal:  Case Rep Endocrinol       Date:  2018-10-24

4.  A Case of Marine-Lenhart Syndrome with a Negative TSH Receptor Antibody Titer Successfully Treated with a Fixed, Low Dose of I (131.).

Authors:  Masahiro Takei; Hiroaki Ishii; Yoshihiko Sato; Mitsuhisa Komatsu
Journal:  Case Rep Endocrinol       Date:  2014-08-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.